Reuters logo
BRIEF-Lipocine - ‍PTAB of USPTO issued a motions decision in interference case between Clarus Therapeutics and Lipocine Inc​
September 21, 2017 / 1:18 PM / 3 months ago

BRIEF-Lipocine - ‍PTAB of USPTO issued a motions decision in interference case between Clarus Therapeutics and Lipocine Inc​

Sept 21 (Reuters) - Lipocine Inc

* Lipocine - ‍ PTAB of USPTO issued a motions decision based on each party’s motions in interference case between Clarus Therapeutics and Lipocine Inc​

* Lipocine- ptab granted Lipocine S motion to deny Clarus previously accorded priority date for 428 patent - SEC filing

* Lipocine Inc - Clarus has a new priority date of April 16, 2014 for Clarus 428 patent​

* Lipocine Inc - PTAB also granted Clarus motion to deny Lipocine S accorded priority date

* Lipocine Inc - Lipocine S has an accorded priority date of May 15, 2015 for Lipocine 692 application Source text: (bit.ly/2jMZgS2) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below